Diabetes mellitus (DM), a chronic metabolic disease characterised by elevated levels of
blood glucose, is among the most common chronic diseases. The incidence and prevalence …

Background: Sexual dysfunction affects millions of people with an increasing prevalence,
worldwide. The pathophysiology of the disease shares several similarities with …

Importance Combining 2 first-line treatments for erectile dysfunction (ED) or initiating other
modalities in addition to a first-line therapy may produce beneficial outcomes. Objective To …

The C-reactive protein-triglyceride glucose index (CTI) is emerging as a novel indicator for
comprehensively assessing the severity of both inflammation and insulin resistance …

Objective This study aims to investigate the relationship between triglyceride glucose index
(TyG) and erectile dysfunction (ED) among United States (US) adult males. Methods A …

Erectile dysfunction (ED) is an early manifestation of cardiovascular (CV) disease. For this
reason, men with ED should be carefully assessed for CV risk factors in order to prevent …

Obesity is a major public health issue worldwide and is frequently associated with erectile
dysfunction (ED). Both conditions may share an internal pathologic environment, also known …

Aim To assess the erectile dysfunction and sex drive in relation to testosterone serum levels
in type 2 Diabetes Mellitus (DM) patients. Materials and Methods A total of 64 patients with …

Background Erectile dysfunction is recognized as one of the complications of diabetes
mellitus. To date, a wide gap of knowledge is present on the efficacy of pharmacological …

Metformin is the first-line oral antidiabetic drug that shows multiple pleiotropic effects of anti-
inflamation, anti-cancer, anti-aging, anti-microbia, anti-atherosclerosis, and immune …